Abstract
Purpose
The purpose of the study is to estimate the proportion of patients who had access to palliative care (PC) and to identify the timing and factors associated with this access.
Methods
A retrospective longitudinal study that included patients who died of advanced cancer between the years of 2010 and 2014 was conducted. The proportion of patients who received PC consultations was compared during those years. Sociodemographic and clinical factors, the timing between first PC consultation and death (early, ≥ 3 months; late, < 3 months), and first PC consultation were assessed.
Results
Of the 1284 studied patients, 988 (76.9%) were referred to PC and 839 (65.3%) had a PC consultation. The proportion of patients who received late PC consultation increased between the years 2010 and 2014 (44.2 vs. 60.4%, p = 0.001). Multivariate analysis revealed that younger age (odds ratio (OR) = 0.98, p = 0.016) and gynecologic cancer (OR = 2.17, p = 0.011) were associated with a PC consultation. Upper gastrointestinal tract (GIT) cancer (OR = 2.42, p = 0.001) and hematologic malignancies (OR = 0.37, p = 0.001) were associated with late PC consultations. The median time interval between the first PC consultation and death was 2.66 months: timing differed significantly among cancer subtypes (p = 0.002).
Conclusion
Most patients received PC consultation before death, and the number of patients with late consultation increased throughout the study. Patients with late referrals could have received PC earlier. The current findings suggest the need to standardize the referral criteria to optimize access to PC.
Similar content being viewed by others
References
World Health Organization. WHO (2014) Global Atlas of Palliative Care at the End of Life. http://www.who.int/nmh/Global_Atlas_of_Palliative_Care.pdf. Accessed 15 March 2017
Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, Dionne-Odom JN, Frost J, Dragnev KH, Hegel MT, Azuero A, Ahles TA (2015) Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol Off J Am Soc Clin Oncol 33(13):1438–1445. https://doi.org/10.1200/JCO.2014.58.6362
Nickolich MS, El-Jawahri A, Temel JS, LeBlanc TW (2016) Discussing the evidence for upstream palliative care in improving outcomes in advanced cancer. Am Soc Clin Oncol Educ B Am Soc Clin Oncol Meet 35:e534–e538. https://doi.org/10.14694/EDBK_159224
Temel JS, Greer JA, Admane S, Gallagher ER, Jackson VA, Lynch TJ, Lennes IT, Dahlin CM, Pirl WF (2011) Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol Off J Am Soc Clin Oncol 29(17):2319–2326. https://doi.org/10.1200/JCO.2010.32.4459
Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, Hull JG, Li Z, Tosteson TD, Byock IR, Ahles TA (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the project ENABLE II randomized controlled trial. JAMA 302(7):741–749. https://doi.org/10.1001/jama.2009.1198
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742. https://doi.org/10.1056/NEJMoa1000678
Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383(9930):1721–1730. https://doi.org/10.1016/S0140-6736(13)62416-2
Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, Ferrell BR, Loscalzo M, Meier DE, Paice JA, Peppercorn JM, Somerfield M, Stovall E, Von Roenn JH (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol Off J Am Soc Clin Oncol 30(8):880–887. https://doi.org/10.1200/JCO.2011.38.5161
Hui D, Cerana MA, Park M, Hess K, Bruera E (2016) Impact of oncologists’ attitudes toward end-of-life care on patients’ access to palliative care. Oncologist 21(9):1149–1155. https://doi.org/10.1634/theoncologist.2016-0090
Yoong J, Park ER, Greer JA, Jackson VA, Gallagher ER, Pirl WF, Back AL, Temel JS (2013) Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med 173(4):283–290. https://doi.org/10.1001/jamainternmed.2013.1874
Rangachari D, Smith TJ (2013) Integrating palliative care in oncology: the oncologist as a primary palliative care provider. Cancer J 19(5):373–378. https://doi.org/10.1097/PPO.0b013e3182a76b9c
Hui D, Kim SH, Roquemore J, Dev R, Chisholm G, Bruera E (2014) Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer 120(11):1743–1749. https://doi.org/10.1002/cncr.28628
Hui D, Kim SH, Kwon JH, Tanco KC, Zhang T, Kang JH, Rhondali W, Chisholm G, Bruera E (2012) Access to palliative care among patients treated at a comprehensive cancer center. Oncologist 17(12):1574–1580. https://doi.org/10.1634/theoncologist.2012-0192
Dos-Anjos CS, Candido PB, Rosa VD, Costa RE, Neves FR, Junqueira-Santos AF, De-Carlo MM, Peria FM, Lima NK (2017) Assessment of the integration between oncology and palliative care in advanced stage cancer patients. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 25(6):1837–1843. https://doi.org/10.1007/s00520-017-3588-9
The Economist Intelligence Unit (2015) The 2015 Quality of Death Index Ranking palliative care across the world. https://www.eiuperspectives.economist.com/sites/default/files/2015%20EIU%20Quality%20of%20Death%20Index%20Oct%2029%20FINAL.pdf. Accessed 5 April 2017
Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175–191. https://doi.org/10.3758/BF03193146
Hui D, Mori M, Watanabe SM, Caraceni A, Strasser F, Saarto T, Cherny N, Glare P, Kaasa S, Bruera E (2016) Referral criteria for outpatient specialty palliative cancer care: an international consensus. Lancet Oncol 17(12):e552–e559. https://doi.org/10.1016/S1470-2045(16)30577-0
Dalal S, Bruera S, Hui D, Yennu S, Dev R, Williams J, Masoni C, Ihenacho I, Obasi E, Bruera E (2016) Use of palliative care services in a tertiary cancer center. Oncologist 21(1):110–118. https://doi.org/10.1634/theoncologist.2015-0234
Amano K, Morita T, Tatara R, Katayama H, Uno T, Takagi I (2015) Association between early palliative care referrals, inpatient hospice utilization, and aggressiveness of care at the end of life. J Palliat Med 18(3):270–273. https://doi.org/10.1089/jpm.2014.0132
Bennett MI, Ziegler L, Allsop M, Daniel S, Hurlow A (2016) What determines duration of palliative care before death for patients with advanced disease? A retrospective cohort study of community and hospital palliative care provision in a large UK city. BMJ Open 6(12):e012576. https://doi.org/10.1136/bmjopen-2016-012576
Faguet GB (2016) Quality end-of-life cancer care: an overdue imperative. Crit Rev Oncol Hematol 108:69–72. https://doi.org/10.1016/j.critrevonc.2016.10.012
Harrington SE, Smith TJ (2008) The role of chemotherapy at the end of life: “when is enough, enough?”. JAMA 299(22):2667–2678. https://doi.org/10.1001/jama.299.22.2667
Rugno FC, Paiva BS, Nunes JS, Paiva CE (2014) “There won’t be anything else...it’s over”: perceptions of women referred to palliative care only. Eur J Oncol Nurs Off J Eur Oncol Nurs Soc 18(3):261–266. https://doi.org/10.1016/j.ejon.2014.01.003
Lowe SS, Nekolaichuk C, Ghosh S, Fainsinger L, Quan H, Fainsinger R (2016) Clinical characteristics of patients having single versus multiple patient encounters within a palliative care programme. BMJ Support Palliat Care. https://doi.org/10.1136/bmjspcare-2015-000985
Hui D, Didwaniya N, Vidal M, Shin SH, Chisholm G, Roquemore J, Bruera E (2014) Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer 120(10):1572–1578. https://doi.org/10.1002/cncr.28614
LeBlanc TW, El-Jawahri A (2015) When and why should patients with hematologic malignancies see a palliative care specialist? Hematology Am Soc Hematol Educ Program 2015(1):471–478. https://doi.org/10.1182/asheducation-2015.1.471
Lefkowits C, Teuteberg W, Courtney-Brooks M, Sukumvanich P, Ruskin R, Kelley JL (2015) Improvement in symptom burden within one day after palliative care consultation in a cohort of gynecologic oncology inpatients. Gynecol Oncol 136(3):424–428. https://doi.org/10.1016/j.ygyno.2014.12.030
Landrum LM, Blank S, Chen LM, Duska L, Bae-Jump V, Lee PS, Levine L, McCourt C, Moore KN, Urban RR (2015) Comprehensive care in gynecologic oncology: the importance of palliative care. Gynecol Oncol 137(2):193–202. https://doi.org/10.1016/j.ygyno.2015.02.026
Bergman J, Laviana AA (2016) Opportunities to maximize value with integrated palliative care. J Multidiscip Healthc 9:219–226. https://doi.org/10.2147/JMDH.S90822
Acknowledgments
This project was supported by Barretos Cancer Hospital internal research funds (PAIP).
Author information
Authors and Affiliations
Contributions
Conceived and designed the experiments: CEP, BSRP, and TCOV. Performed the experiments: TCOV, BSRP, and CEP. Analyzed the data: MAO and CEP. Wrote the paper: TCOV, BSRP, and CEP.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
de Oliveira Valentino, T.C., Paiva, B.S.R., de Oliveira, M.A. et al. Factors associated with palliative care referral among patients with advanced cancers: a retrospective analysis of a large Brazilian cohort. Support Care Cancer 26, 1933–1941 (2018). https://doi.org/10.1007/s00520-017-4031-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-017-4031-y